Terms: = Sarcomas AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474
28 results:
1. Application of the Yamanaka Transcription Factors
Aguirre M; Escobar M; Forero Amézquita S; Cubillos D; Rincón C; Vanegas P; Tarazona MP; Atuesta Escobar S; Blanco JC; Celis LG
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761837
[TBL] [Abstract] [Full Text] [Related]
2. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
Martins-Neves SR; Sampaio-Ribeiro G; Gomes CMF
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176108
[TBL] [Abstract] [Full Text] [Related]
3. LINC00629 protects osteosarcoma cell from ER stress-induced apoptosis and facilitates tumour progression by elevating klf4 stability.
Wang Y; Zheng S; Han J; Li N; Ji R; Li X; Han C; Zhao W; Zhang L
J Exp Clin Cancer Res; 2022 Dec; 41(1):354. PubMed ID: 36539799
[TBL] [Abstract] [Full Text] [Related]
4. Pluripotency Stemness and Cancer: More Questions than Answers.
Hatina J; Kripnerová M; Houdek Z; Pešta M; Tichánek F
Adv Exp Med Biol; 2022; 1376():77-100. PubMed ID: 34725790
[TBL] [Abstract] [Full Text] [Related]
5. CRISPR/Cas9-mediated overexpression of long non-coding RNA SRY-box transcription factor 21 antisense divergent transcript 1 regulates the proliferation of osteosarcoma by increasing the expression of mechanistic target of rapamycin kinase and Kruppel-like factor 4.
Zhang W; Wang Q; Du H; Jiang S
Bioengineered; 2022 Mar; 13(3):6678-6687. PubMed ID: 34696664
[TBL] [Abstract] [Full Text] [Related]
6. Regulation of sarcomagenesis by the empty spiracles homeobox genes EMX1 and EMX2.
Jimenez-García MP; Lucena-Cacace A; Otero-Albiol D; Carnero A
Cell Death Dis; 2021 May; 12(6):515. PubMed ID: 34016958
[TBL] [Abstract] [Full Text] [Related]
7. miR-145 suppresses epithelial-mesenchymal transition by targeting stem cells in Ewing sarcoma cells.
Guzel Tanoglu E; Ozturk S
Bratisl Lek Listy; 2021; 122(1):71-77. PubMed ID: 33393324
[TBL] [Abstract] [Full Text] [Related]
8. Acquisition of cancer stem cell properties in osteosarcoma cells by defined factors.
Fujiwara S; Kawamoto T; Kawakami Y; Koterazawa Y; Hara H; Takemori T; Kitayama K; Yahiro S; Kakutani K; Matsumoto T; Matsushita T; Niikura T; Koyanagi-Aoi M; Aoi T; Kuroda R; Akisue T
Stem Cell Res Ther; 2020 Oct; 11(1):429. PubMed ID: 33008481
[TBL] [Abstract] [Full Text] [Related]
9. A multimodal treatment of carbon ions irradiation, miRNA-34 and mTOR inhibitor specifically control high-grade chondrosarcoma cancer stem cells.
Vares G; Ahire V; Sunada S; Ho Kim E; Sai S; Chevalier F; Romeo PH; Yamamoto T; Nakajima T; Saintigny Y
Radiother Oncol; 2020 Sep; 150():253-261. PubMed ID: 32717360
[TBL] [Abstract] [Full Text] [Related]
10. Mechanisms underlying the promotion of osteosarcoma cell proliferation and invasion by lncRNA PBB12.
Ma T; Liu A; Xu D; Zhang T
Oncol Rep; 2020 Feb; 43(2):736-746. PubMed ID: 31894336
[TBL] [Abstract] [Full Text] [Related]
11. Different methylation levels in the klf4, ATF3 and DLEC1 genes in the myometrium and in corpus uteri mesenchymal tumours as assessed by MS-HRM.
Braný D; Dvorská D; Grendár M; Ňachajová M; Szépe P; Lasabová Z; Žúbor P; Višňovský J; Halášová E
Pathol Res Pract; 2019 Aug; 215(8):152465. PubMed ID: 31176573
[TBL] [Abstract] [Full Text] [Related]
12. klf4 functions as an oncogene in promoting cancer stem cell-like characteristics in osteosarcoma cells.
Qi XT; Li YL; Zhang YQ; Xu T; Lu B; Fang L; Gao JQ; Yu LS; Zhu DF; Yang B; He QJ; Ying MD
Acta Pharmacol Sin; 2019 Apr; 40(4):546-555. PubMed ID: 29930276
[TBL] [Abstract] [Full Text] [Related]
13. Stem cell transcription factor SOX2 in synovial sarcoma and other soft tissue tumors.
Zayed H; Petersen I
Pathol Res Pract; 2018 Jul; 214(7):1000-1007. PubMed ID: 29773426
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of klf4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells.
Li Y; Xian M; Yang B; Ying M; He Q
Stem Cell Reports; 2017 Jun; 8(6):1617-1629. PubMed ID: 28552603
[TBL] [Abstract] [Full Text] [Related]
15. miR-10b promotes invasion by targeting klf4 in osteosarcoma cells.
Wang J; Wang B; Chen LQ; Yang J; Gong ZQ; Zhao XL; Zhang CQ; Du KL
Biomed Pharmacother; 2016 Dec; 84():947-953. PubMed ID: 27764757
[TBL] [Abstract] [Full Text] [Related]
16. Krüppel-like factor 4 promotes human osteosarcoma growth and metastasis via regulating CRYAB expression.
Zhang L; Zhang L; Xia X; He S; He H; Zhao W
Oncotarget; 2016 May; 7(21):30990-1000. PubMed ID: 27105535
[TBL] [Abstract] [Full Text] [Related]
17. FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways.
Kelleher FC; O'Sullivan H
Oncotarget; 2016 Jul; 7(27):42792-42804. PubMed ID: 27074562
[TBL] [Abstract] [Full Text] [Related]
18. Successful induction of sclerostin in human-derived fibroblasts by 4 transcription factors and its regulation by parathyroid hormone, hypoxia, and prostaglandin E2.
Fujiwara M; Kubota T; Wang W; Ohata Y; Miura K; Kitaoka T; Okuzaki D; Namba N; Michigami T; Kitabatake Y; Ozono K
Bone; 2016 Apr; 85():91-8. PubMed ID: 26851122
[TBL] [Abstract] [Full Text] [Related]
19. Krüppel-like factor 4 promotes high-mobility group box 1-induced chemotherapy resistance in osteosarcoma cells.
Huang J; Liu K; Song D; Ding M; Wang J; Jin Q; Ni J
Cancer Sci; 2016 Mar; 107(3):242-9. PubMed ID: 26676883
[TBL] [Abstract] [Full Text] [Related]
20. Osteosarcoma Stem Cells Have Active Wnt/β-catenin and Overexpress SOX2 and klf4.
Martins-Neves SR; Corver WE; Paiva-Oliveira DI; van den Akker BE; Briaire-de-Bruijn IH; Bovée JV; Gomes CM; Cleton-Jansen AM
J Cell Physiol; 2016 Apr; 231(4):876-86. PubMed ID: 26332365
[TBL] [Abstract] [Full Text] [Related]
[Next]
